BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38033126)

  • 1. Mutational analysis and clinical investigations of medically diagnosed GSD 1a patients from Pakistan.
    Gul B; Firasat S; Shan T; Tehreem R; Afshan K
    PLoS One; 2023; 18(11):e0288965. PubMed ID: 38033126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heterogeneous phenotypes in Chinese glycogen storage disease type Ia patients with homozygous G727T mutation].
    Qiu ZQ; Wei M; Liu G; Liu GY
    Zhonghua Er Ke Za Zhi; 2003 Apr; 41(4):252-5. PubMed ID: 14754525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel homozygous no-stop mutation in G6PC gene from a Chinese patient with glycogen storage disease type Ia.
    Gu LL; Li XH; Han Y; Zhang DH; Gong QM; Zhang XX
    Gene; 2014 Feb; 536(2):362-5. PubMed ID: 24355556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.
    Peeks F; Steunenberg TAH; de Boer F; Rubio-Gozalbo ME; Williams M; Burghard R; Rajas F; Oosterveer MH; Weinstein DA; Derks TGJ
    J Inherit Metab Dis; 2017 Sep; 40(5):695-702. PubMed ID: 28397058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR/Cas9-based gene editing.
    Arnaoutova I; Zhang L; Chen HD; Mansfield BC; Chou JY
    Mol Ther; 2021 Apr; 29(4):1602-1610. PubMed ID: 33359667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia.
    Lee YM; Pan CJ; Koeberl DD; Mansfield BC; Chou JY
    Mol Genet Metab; 2013 Nov; 110(3):275-80. PubMed ID: 23856420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
    Kim YM; Choi JH; Lee BH; Kim GH; Kim KM; Yoo HW
    Orphanet J Rare Dis; 2020 Feb; 15(1):45. PubMed ID: 32046761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.
    Chou JY; Mansfield BC
    Hum Mutat; 2008 Jul; 29(7):921-30. PubMed ID: 18449899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.
    Saeed A; Hoogerland JA; Wessel H; Heegsma J; Derks TGJ; van der Veer E; Mithieux G; Rajas F; Oosterveer MH; Faber KN
    Hum Mol Genet; 2020 Jan; 29(2):264-273. PubMed ID: 31813960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of glycogen storage disease type Ia in Iranian Azeri Turks: identification of a novel mutation.
    Mahmoud SK; Khorrami A; Rafeey M; Ghergherehchi R; Sima MD
    J Genet; 2017 Mar; 96(1):19-23. PubMed ID: 28360385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases.
    Liang Y; Du C; Wei H; Zhang C; Zhang M; Hu M; Fang F; Luo X
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1444. PubMed ID: 32772503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation.
    Matern D; Seydewitz HH; Bali D; Lang C; Chen YT
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S10-9. PubMed ID: 12373566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.
    Hoogerland JA; Peeks F; Hijmans BS; Wolters JC; Kooijman S; Bos T; Bleeker A; van Dijk TH; Wolters H; Gerding A; van Eunen K; Havinga R; Pronk ACM; Rensen PCN; Mithieux G; Rajas F; Kuipers F; Reijngoud DJ; Derks TGJ; Oosterveer MH
    J Inherit Metab Dis; 2021 Jul; 44(4):879-892. PubMed ID: 33739445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants.
    Skakic A; Djordjevic M; Sarajlija A; Klaassen K; Tosic N; Kecman B; Ugrin M; Spasovski V; Pavlovic S; Stojiljkovic M
    Clin Genet; 2018 Feb; 93(2):350-355. PubMed ID: 28685844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous mutations in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type Ia.
    Takahashi K; Akanuma J; Matsubara Y; Fujii K; Kure S; Suzuki Y; Wataya K; Sakamoto O; Aoki Y; Ogasawara M; Ohura T; Miyabayashi S; Narisawa K
    Am J Med Genet; 2000 May; 92(2):90-4. PubMed ID: 10797430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
    Yavarow ZA; Kang HR; Waskowicz LR; Bay BH; Young SP; Yen PM; Koeberl DD
    Hum Mol Genet; 2020 Jan; 29(2):286-294. PubMed ID: 31816064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid screening of 12 common mutations in Turkish GSD 1a patients using electronic DNA microarray.
    Eminoglu TF; Ezgu FS; Hasanoglu A; Tumer L
    Gene; 2013 Apr; 518(2):346-50. PubMed ID: 23352793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report.
    Wang W; Yu R; Tan W; Dan Y; Deng G; Xia J
    BMC Med Genet; 2019 May; 20(1):85. PubMed ID: 31109299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
    Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia.
    Zhang L; Lee C; Arnaoutova I; Anduaga J; Starost MF; Mansfield BC; Chou JY
    Biochem Biophys Res Commun; 2020 Jun; 527(3):824-830. PubMed ID: 32430177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.